Back to Sean OMara, MD JD, Health & Performance Optimizing

Seriously, please watch this before you take GLP-1s (reta, ozempic, tirzepatide)

In a Nutshell

Dr. Sha Omeira warns that GLP-1 drugs like Ozempic and tirzepatide suppress appetite and cause weight loss but also strip away muscle and fail to distinguish between harmful visceral fat and beneficial subcutaneous fat. Weight returns rapidly after stopping, often as disease-driving fat, creating dependency unless tracked properly. He insists on baseline and follow-up MRIs instead of scales to measure real changes in muscle and visceral fat, and stresses lifestyle change over relying on medication.

AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

If you're thinking about taking a Zepic, Tzepides, reatride or any of the GLP-1 drugs for that matter, or someone close to you is, please give me the next few minutes before you make that decision. I'm Dr. Sha Omeira. I'm a physician and researcher, and I've spent years treating patients for what's underneath obesity, visceral fat disease, the metabolic damage, the things most doctors don't even measure.

In this video, I'll explain what these drugs actually do inside your body, the side effects almost nobody else warns you about, what happens when you stop taking them, the questions to ask before you start, and if you're already on one, exactly what to do so you don't end up regretting it.

What they are good at is suppressing the appetite. And because of that, your body shrinks because you're not eating as much and you become really catabolic. Now, to be sure, mostly you're catabolic consuming fat tissue. But what these drugs don't differentiate is the type of fat.

Does your doctor before he or she writes a script, do they know the difference between subcutaneous fat and visceral fat disease, inflammatory fat disease around your heart, around your organs, and filling your muscle? Should they be writing the script if they don't know the difference between that and that there's different types of subcutaneous fat, one is beneficial, the other is disease?

This is the problem with modern-day medicine. They don't know. And it's not taught in medical school, but I want to show you that difference.

Sign in to read the full notes

Get access to AI-generated notes, topic timestamps, and more.